Advanced search
Publication Cover
Leukemia & Lymphoma Volume 49, 2008 - Issue 4
Submit an article Journal homepage
84
Views
4
CrossRef citations to date
0
Altmetric
Focused Reviews in CML

Signal interception-based therapies – A double-edged sword in Bcr/abl-induced malignancies?

Eva Zebedin Institute of Pharmacology, Medical University of Vienna, Vienna, Austria
,
Michael Freissmuth Institute of Pharmacology, Medical University of Vienna, Vienna, Austria
&
Veronika Sexl Institute of Pharmacology, Medical University of Vienna, Vienna, AustriaCorrespondence[email protected]
Pages 620-624 | Published online: 01 Jul 2009

Citations (4)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Bo Zuo, Mei Li, Yulan Liu, Kun Li, Shuyun Ma, Meihua Cui, Yazhen Qin, Honghu Zhu, Xiuying Pan, Jingzhu Guo, Zonghan Dai & Weidong Yu. (2015) G-protein coupled receptor 34 activates Erk and phosphatidylinositol 3-kinase/Akt pathways and functions as alternative pathway to mediate p185Bcr–Abl-induced transformation and leukemogenesis. Leukemia & Lymphoma 56:7, pages 2170-2181.
Read now
Michaela Prchal-Murphy, Eva Maria Putz, Michael Freissmuth, Veronika Sexl & Eva Zebedin-Brandl. (2013) Targeting PI3Kδ. OncoImmunology 2:1.
Read now

Articles from other publishers (2)

Wen-Jing Yang, Lin Shi, Xiao-Min Wang & Guo-Wang Yang. (2021) Heparanase is a novel biomarker for immune infiltration and prognosis in breast cancer. Aging 13:16, pages 20836-20852.
Crossref
Sandra Beer-Hammer, Eva Zebedin, Max von Holleben, Judith Alferink, Bernhard Reis, Philipp Dresing, Daniel Degrandi, Stefanie Scheu, Emilio Hirsch, Veronika Sexl, Klaus Pfeffer, Bernd Nürnberg & Roland P Piekorz. (2010) The catalytic PI3K isoforms p110γ and p110δ contribute to B cell development and maintenance, transformation, and proliferation. Journal of Leukocyte Biology 87:6, pages 1083-1095.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.